FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

The Harvard Drug Group Alprazolam Tablets Recall

Alprazolam Tablets, USP, 0

The Harvard Drug Group · Livonia, MI

Risk level
Class II
Reported by FDA
Oct 25, 2017
Recall ID
D-0013-2018
Check your lot numberHow we source this data

Summary

The Harvard Drug Group recalled Alprazolam Tablets starting Sep 26, 2017. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0013-2018 on Oct 25, 2017. Reason: Failed Impurities/Degradation Specifications: Out-of-specification result for an unknown impurity. Status: Terminated.

Why it was recalled

Failed Impurities/Degradation Specifications: Out-of-specification result for an unknown impurity.

Product description

Alprazolam Tablets, USP, 0.25 mg, 100-count Unit Dose tablets per carton, Rx Only, Manufactured by: Watson Pharma Private Limited, Verna, Salcette Goa 403 722 INDIA; Distributed by: Actavis Pharma, Inc., Parsippany, NJ 07054; Distributed by: Major Pharmaceuticals, 17177 N. Laurel Park Dr., Suite 233, Livonia, MI 48152, NDC 0904-5858-61.

Lot numbers, UPCs & expiration codes

Lot 1274C151A, Exp 10/17

Where it was sold

Nationwide in the USA

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0013-2018
Classification
Class II
Status
Terminated
Recall initiated
Sep 26, 2017
FDA report date
Oct 25, 2017
Quantity
3,935 cartons
Recall type
Voluntary: Firm initiated
Recalling firm
The Harvard Drug Group

Original FDA data

Every field from FDA enforcement report D-0013-2018, exactly as published.

Show all FDA fields
City
Livonia
State
MI
Status
Terminated
Country
United States
Event ID
78162
Address
17177 N Laurel Park Dr Ste 233
Code information
Lot 1274C151A, Exp 10/17
Postal code
48152-3951
Report date
Oct 25, 2017
Product type
Drugs
Recall number
D-0013-2018
Classification
Class II
Recalling firm
The Harvard Drug Group
Product quantity
3,935 cartons
Termination date
Apr 29, 2020
Reason for recall
Failed Impurities/Degradation Specifications: Out-of-specification result for an unknown impurity.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Alprazolam Tablets, USP, 0.25 mg, 100-count Unit Dose tablets per carton, Rx Only, Manufactured by: Watson Pharma Private Limited, Verna, Salcette Goa 403 722 INDIA; Distributed by: Actavis Pharma, Inc., Parsippany, NJ 07054; Distributed by: Major Pharmaceuticals, 17177 N. Laurel Park Dr., Suite 233, Livonia, MI 48152, NDC 0904-5858-61.
Distribution pattern
Nationwide in the USA
Recall initiation date
Sep 26, 2017
Initial firm notification
Letter
Center classification date
Oct 19, 2017

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0013-2018, published Oct 25, 2017. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls